Source link : https://www.newshealth.biz/health-news/fda-clears-nsaid-triptan-combo-for-migraine-in-adults/
The US Food and Drug Administration (FDA) has approved a novel formulation combining rizatriptan and the nonsteroidal anti-inflammatory drug meloxicam (Symbravo, Axome Therapeutics) for the acute treatment of migraine with or without aura in adults. “Symbravo incorporates Axsome’s rapid absorption technology and mechanisms that target multiple migraine attack pathways,” the company explained in a news […]
Author : News Health
Publish date : 2025-01-31 16:56:23
Copyright for syndicated content belongs to the linked Source.